Matches in SemOpenAlex for { <https://semopenalex.org/work/W4312756686> ?p ?o ?g. }
Showing items 1 to 54 of
54
with 100 items per page.
- W4312756686 endingPage "135" @default.
- W4312756686 startingPage "135" @default.
- W4312756686 abstract "Introduction: Gastrointestinal (GIT) mucositis is a common problem associated with chemotherapy. Dacomitinib is a chemotherapeutic drug that treats nonsmall cell lung cancer. It irreversibly binds to the receptors at the ileal epithelial cells, leading to mucosal injury. Baicalin (BA) is a flavonoid with anti-inflammatory, antifibrosis, and antibarrier disruption properties. Aim: This work aimed to investigate the possible protective effects of BA on dacomitinib-induced ileal mucositis in rats by histological and immunohistochemical studies. Materials and Methods: 60 Wistar rats (8–12 weeks) were used (180–200 g) and divided into 6 groups (10 rats each). Group 1: Control; Group 2 (dacomitinib): Rats received dacomitinib 7.5 mg/kg/day orally; Group 3 (dacomitinib + carboxyl methylcellulose [CMC]): Rats received dacomitinib 7.5 mg/kg/day and 0.5% CMC orally; Group 4 (dacomitinib + BA low dose): Rats received low-dose BA 30 mg/kg/day and 7.5 mg/kg/day dacomitinib orally; Group 5 (dacomitinib + BA mid dose): Rats received mid-dose BA 60 mg/kg/day and 7.5 mg/kg/day dacomitinib orally; Group 6 (dacomitinib + BA high dose): Rats received high-dose BA 100 mg/kg/day and 7.5 mg/kg/day dacomitinib orally. Results: Dacomitinib group showed short villi, desquamated epithelium, congested blood vessels, inflammatory cellular infiltrations, dilated lacteals, and wide spaces between the crypts. There is a significant increase in collagen fibers and number of tumor necrosis factor-alpha and proliferating cell nuclear antigen-positive cells. Further, there were lost epithelial cadherin (E-cadherin) and epidermal growth factor receptor immunohistochemical reaction. The previous findings were ameliorated by BA in a dose-dependent manner. Conclusion: BA has a protective effect through its anti-inflammatory, antifibrosis, and antibarrier disruption effects. Hence, BA is considered as a promising new drug for the treatment of chemotherapy-associated GIT problems, especially dacomitinib." @default.
- W4312756686 created "2023-01-05" @default.
- W4312756686 creator A5009661053 @default.
- W4312756686 creator A5076574341 @default.
- W4312756686 date "2023-01-01" @default.
- W4312756686 modified "2023-09-28" @default.
- W4312756686 title "Histomorphological and immunohistochemical study of dacomitinib-induced ileal mucositis in rats with the possible protection by baicalin" @default.
- W4312756686 doi "https://doi.org/10.4103/jmau.jmau_115_20" @default.
- W4312756686 hasPublicationYear "2023" @default.
- W4312756686 type Work @default.
- W4312756686 citedByCount "0" @default.
- W4312756686 crossrefType "journal-article" @default.
- W4312756686 hasAuthorship W4312756686A5009661053 @default.
- W4312756686 hasAuthorship W4312756686A5076574341 @default.
- W4312756686 hasConcept C126322002 @default.
- W4312756686 hasConcept C179998833 @default.
- W4312756686 hasConcept C185592680 @default.
- W4312756686 hasConcept C204232928 @default.
- W4312756686 hasConcept C2778496288 @default.
- W4312756686 hasConcept C2780113650 @default.
- W4312756686 hasConcept C29730261 @default.
- W4312756686 hasConcept C43617362 @default.
- W4312756686 hasConcept C71924100 @default.
- W4312756686 hasConcept C98274493 @default.
- W4312756686 hasConceptScore W4312756686C126322002 @default.
- W4312756686 hasConceptScore W4312756686C179998833 @default.
- W4312756686 hasConceptScore W4312756686C185592680 @default.
- W4312756686 hasConceptScore W4312756686C204232928 @default.
- W4312756686 hasConceptScore W4312756686C2778496288 @default.
- W4312756686 hasConceptScore W4312756686C2780113650 @default.
- W4312756686 hasConceptScore W4312756686C29730261 @default.
- W4312756686 hasConceptScore W4312756686C43617362 @default.
- W4312756686 hasConceptScore W4312756686C71924100 @default.
- W4312756686 hasConceptScore W4312756686C98274493 @default.
- W4312756686 hasIssue "3" @default.
- W4312756686 hasLocation W43127566861 @default.
- W4312756686 hasOpenAccess W4312756686 @default.
- W4312756686 hasPrimaryLocation W43127566861 @default.
- W4312756686 hasRelatedWork W1996705473 @default.
- W4312756686 hasRelatedWork W2005555474 @default.
- W4312756686 hasRelatedWork W2009262198 @default.
- W4312756686 hasRelatedWork W2024226989 @default.
- W4312756686 hasRelatedWork W2024980041 @default.
- W4312756686 hasRelatedWork W2160222891 @default.
- W4312756686 hasRelatedWork W2526163481 @default.
- W4312756686 hasRelatedWork W2998707267 @default.
- W4312756686 hasRelatedWork W3164102798 @default.
- W4312756686 hasRelatedWork W3191366563 @default.
- W4312756686 hasVolume "11" @default.
- W4312756686 isParatext "false" @default.
- W4312756686 isRetracted "false" @default.
- W4312756686 workType "article" @default.